Town & Country Bank & Trust CO dba First Bankers Trust CO Takes Position in AstraZeneca PLC $AZNCF

Town & Country Bank & Trust CO dba First Bankers Trust CO bought a new position in shares of AstraZeneca PLC (OTCMKTS:AZNCF) in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor bought 6,851 shares of the company’s stock, valued at approximately $1,351,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Hughes Financial Services LLC acquired a new stake in AstraZeneca in the 4th quarter valued at $34,000. Fairscale Capital LLC acquired a new position in AstraZeneca during the fourth quarter worth $37,000. Mascoma Wealth Management LLC acquired a new position in AstraZeneca during the fourth quarter worth $46,000. Aventus Investment Advisors Inc. purchased a new position in AstraZeneca during the first quarter valued at $46,000. Finally, Resources Management Corp CT ADV purchased a new position in AstraZeneca during the fourth quarter valued at $61,000. Hedge funds and other institutional investors own 40.87% of the company’s stock.

AstraZeneca Stock Performance

AZNCF opened at $187.10 on Monday. AstraZeneca PLC has a twelve month low of $122.26 and a twelve month high of $195.00. The company has a 50-day moving average price of $187.10 and a 200 day moving average price of $186.05.

AstraZeneca Profile

AstraZeneca (OTCMKTS:AZNCF) is a global biopharmaceutical company that focuses on the discovery, development, manufacturing and commercialization of prescription medicines. The company’s research and development efforts are concentrated in three main therapeutic areas: oncology; cardiovascular, renal and metabolism; and respiratory, inflammation and autoimmunity. AstraZeneca’s product portfolio includes targeted therapies for lung and breast cancers, novel agents for heart failure and chronic kidney disease, and inhaled treatments for asthma and chronic obstructive pulmonary disease.

The company was formed in 1999 through the merger of Sweden’s Astra AB and the United Kingdom’s Zeneca Group, creating one of the world’s largest pharmaceutical firms.